Driver: Favorable reimbursement scenario in developed countries
The developed countries are reported to have favorable reimbursement scenarios for bowel management products, owing to which the demand for these products is expected to grow positively during the study period.
Restraint: Patient preference for non-invasive clinical management of FI
Currently, FI can be managed invasively (surgically) or non-invasively. Standard modes of surgical treatment include the injection of biomaterials into the anal canal, radiofrequency treatment of the anal canal, surgical repair of anal muscle injuries, sacral nerve stimulation, artificial bowel sphincter, muscle transposition to reinforce the anal sphincter, and the creation of a stoma. These often require long-term patient rehabilitation and maybe highly inconvenient and even severely painful.
Growth in the bowel management systems market is mainly driven by factors such as the expanding target patient population, the rapidly growing geriatric population, availability of technologically advanced bowel management products, and the favorable reimbursement scenario in developed countries.
Global Leaders:
Some of the major players operating in the bowel management systems market are Coloplast (Denmark), Medtronic (Ireland), 3M (US), B. Braun (Germany), C.R. Bard (US), Consure Medical (India), Cogentix Medical (US), Aquaflush Medical Limited (UK), Axonics Modulation Technologies (US), ConvaTec (UK), Hollister (US), MBH-International A/S (Denmark), Mederi Therapeutics Inc. (US), Welland Medical limited (UK), and Wellspect HealthCare (Sweden).
An analysis of market developments between 2015 and 2018 revealed that growth strategies such as product launches and approvals, agreements, expansions, and acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the bowel management systems market. Among these, product launches and approvals were the most widely adopted growth strategies.
As of 2017, Coloplast (Denmark) is the key player in the global bowel management systems market. The company’s growth in the bowel management systems market is supported by its strong pipeline of products, sustained cost discipline, and adoption of new growth strategies to enhance its product portfolio based on new technologies available in the market. The company’s large share of the market was also supported by the launch of its SenSura Mio product portfolio in various important markets and the acquisitions of various regional players in the continence and ostomy market.
As of 2017, ConvaTec (UK) is among the key manufacturers of bowel management systems. The company markets a comprehensive product portfolio of ostomy systems, accessories, and fecal incontinence products to address customer needs and preferences.
As of 2017, Hollister (US) holds a significant share in the global bowel management market owing to its targeted product portfolio of bowel care products, which serves as an important factor for its future growth. The company is focusing on expanding its presence across the globe through various inorganic strategies. In May 2018, the company established a new distribution center in Oud Gastel, in the Netherlands. This new center is aimed at catering to the growing customer needs and it will help the company strengthen its presence in the European region. Thus, with the growing efforts of the company to expand its critical care segment, the company is expected to witness growth in the bowel management systems market in the coming years.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
